Status:
COMPLETED
AnalyST Treadmill Study
Lead Sponsor:
Abbott Medical Devices
Conditions:
Ischemic Heart Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the study is to collect information on the naturally occurring variations in ST deviations at different heart rates, as detected by the AnalyST and AnalyST Accel Implantable Cardiover...
Eligibility Criteria
Inclusion
- Patient has received or is scheduled to receive a St Jude Medical AnalyST or AnalyST Accel ICD;
- Patient has documented ischemic heart disease.
Exclusion
- Patient has an indication for ventricular pacing;
- Patient has chronotropic incompetence or insufficiency;
- Patient has a contraindication to stress testing;
- Patient is physically unable to complete the stress test protocol;
- The patient has persistent or permanent atrial fibrillation (AF);
- Patient is unable to comply with the protocol and follow-up schedule based on geographic location or for any reason;
- Patient is pregnant;
- Patient is minor (\< 18 years old).
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2011
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00949000
Start Date
July 1 2009
End Date
February 1 2011
Last Update
February 4 2019
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum Coburg
Coburg, Bavaria, Germany, 96450
2
Kerckhoff-Klinik
Bad Nauheim, Hesse, Germany, 61321
3
Medizinische Einrichtungen der RWTH Aachen
Aachen, N. Rhin, Germany, 52074
4
Klinikum der Stadt Ludwigshafen am Rhein
Ludwigshafen, N. Rhin, Germany, 67063